BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 4746315)

  • 1. Insulin antibody production studied quantitatively with a modified radioimmunoassay technique and with radioimmunoelectrophoresis in patients treated with monocomponent (MC) insulin.
    Bruni B; Ricci C; Giolitti A; Osenda M; D'Alberto M; Turco GL
    J Nucl Biol Med; 1973; 17(3):123. PubMed ID: 4746315
    [No Abstract]   [Full Text] [Related]  

  • 2. Insulin antibodies in diabetics receiving a single type of insulin.
    Mincu I; Cheţa D
    Med Interne; 1982; 20(1):9-13. PubMed ID: 6765628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experiences in the treatment of diabetes with insulins of monocomponent (MC) and monospecies (MS) type].
    Andreani D; Iavicoli M; Colletti A; Menzinger G
    Folia Endocrinol; 1972 Dec; 25(6):516-39. PubMed ID: 4581824
    [No Abstract]   [Full Text] [Related]  

  • 4. Measurement of immune complexes in insulin-treated diabetics.
    Jayarao KS; Faulk WP; Karam JH; Grodsky GM; Forsham PH
    J Immunol Methods; 1973 Dec; 3(4):337-45. PubMed ID: 4591347
    [No Abstract]   [Full Text] [Related]  

  • 5. Insulin immunology: humoral and cellular aspects in mono-component insulin treated patients.
    Devlin JG; Maguire O; Parameswaran V; Blake PJ
    Postgrad Med J; 1979; 55 Suppl 2():14-8. PubMed ID: 482193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of insulin antibodies in insulin treated patients.
    Giampietro O; Giannessi D; Del Chicca MG; Luche AD; Zucchelli GC; Navalesi R
    J Nucl Med Allied Sci; 1980; 24(3-4):153-8. PubMed ID: 7019394
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunogenicity of human insulin (Novo) or pork monocomponent insulin in HLA-DR-typed insulin-dependent diabetic individuals.
    Schernthaner G; Borkenstein M; Fink M; Mayr WR; Menzel J; Schober E
    Diabetes Care; 1983; 6 Suppl 1():43-8. PubMed ID: 6343038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection of insulin-neutralizing antibodies using I-125-bound insulin].
    Láng I; Stützel M; Littmann L; Balázsi I
    Orv Hetil; 1974 Jan; 115(4):211-2. PubMed ID: 4839803
    [No Abstract]   [Full Text] [Related]  

  • 9. Isolation and characterization of soluble insulin-anti-insulin immune complexes formed in vitro and in vivo in sera from patients with diabetes mellitus.
    Kilpatrick JM; Virella G
    Clin Exp Immunol; 1980 Jun; 40(3):445-52. PubMed ID: 6998615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of the antibody anti-insulin titer using Christiansen's radioimmunoelectrophoresis in clinical diabetology].
    Bruni Bocher K; Castellazzi R; D'Adda A; Gamba S; Giolitti A; Rittatore R; Turco GL; Bruni B
    Ann Osp Maria Vittoria Torino; 1975; 18(1-6):26-52. PubMed ID: 1242089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of monocomponent insulin serum anti-insulin antibody levels (author's transl)].
    García de los Ríos M; Mella I; Durruty P; Ruiz F; López G; Tapia JC; González G
    Rev Med Chil; 1981 Jun; 109(6):509-15. PubMed ID: 7036310
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experiences with monocomponent insulin treatment].
    Korp W; Levett RE
    Wien Klin Wochenschr; 1973 May; 85(18):326-30. PubMed ID: 4699490
    [No Abstract]   [Full Text] [Related]  

  • 13. Soluble immune complexes in the sera of newly diagnosed insulin-dependent diabetics and in treated diabetics.
    Irvine WJ; Al-Khateeb SF; Di Mario U; Feek CM; Gray RS; Edmond B; Duncan LJ
    Clin Exp Immunol; 1977 Oct; 30(1):16-21. PubMed ID: 606435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monocomponent insulin in maturity onset diabetes mellitus.
    Viswanathan M; Ramachandran A; Snehalatha C; Viswanathan M
    J Indian Med Assoc; 1981 Mar; 76(5):73-5. PubMed ID: 7021694
    [No Abstract]   [Full Text] [Related]  

  • 15. Insulin therapy in patients with systemic insulin allergy.
    Mattson JR; Patterson R; Roberts M
    Arch Intern Med; 1975 Jun; 135(6):818-21. PubMed ID: 1130927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Proceedings: Formation of anti-insulin antibodies IgG in diabetic patients treated with conventional insulin monocomposed or monospecific].
    Weber HU; Sourisseau D; Zahnd GR
    Helv Med Acta; 1974 May; 37(5-6):367. PubMed ID: 4410557
    [No Abstract]   [Full Text] [Related]  

  • 17. [A new insulin radioimmunotest and its use in the determination of anti-insulin antibodies].
    Menzel EJ; Smolen JS; Kojer M
    Acta Med Austriaca Suppl; 1979; 6():399-401. PubMed ID: 162424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does insulin administration contribute to immune complex formation in diabetes?
    Campbell LV; Charlesworth JA; Pasterfield GV; Jenkins A; Pussell BA
    Clin Exp Immunol; 1984 Nov; 58(2):255-63. PubMed ID: 6388921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of insulin antibodies with 125I-insulin in vitro.
    Balázsi I; Stützel M; Lang I; Littmann L
    Rev Roum Med Intern; 1974; 11(1):95-7. PubMed ID: 4407676
    [No Abstract]   [Full Text] [Related]  

  • 20. [Serum levels of insulin-binding antibodies treated with monocomponent insulin].
    Czyzyk A; Lawecki J; Rogala H; Miedzińska E; Popik-Hankiewicz A
    Pol Tyg Lek; 1974 Feb; 29(8):301-4. PubMed ID: 4856084
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.